These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33781159)

  • 1. Treatment of tardive dyskinesia: a review and update for dermatologists managing delusions of parasitosis.
    Cheng C; Brownstone N; Koo J
    J Dermatolog Treat; 2022 May; 33(3):1319-1323. PubMed ID: 33781159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive Dyskinesia: Treatment Update.
    Arya D; Khan T; Margolius AJ; Fernandez HH
    Curr Neurol Neurosci Rep; 2019 Aug; 19(9):69. PubMed ID: 31420757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valbenazine for the treatment of tardive dyskinesia.
    Seeberger LC; Hauser RA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1279-1287. PubMed ID: 28699794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delusions of parasitosis; suggested dialogue between dermatologist and patient.
    Patel V; Koo JY
    J Dermatolog Treat; 2015 Oct; 26(5):456-60. PubMed ID: 25490455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA-Approved Medications to Treat Tardive Dyskinesia.
    McEvoy JP
    J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31851437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delusions of parasitosis. A dermatologist's guide to diagnosis and treatment.
    Koo J; Lee CS
    Am J Clin Dermatol; 2001; 2(5):285-90. PubMed ID: 11721647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antipsychotic-induced tardive syndromes].
    Fleischhacker WW; Hofer A; Jagsch C; Pirker W; Psota G; Rittmannsberger H; Seppi K
    Neuropsychiatr; 2016 Sep; 30(3):123-130. PubMed ID: 27580887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crushing deutetrabenazine for treatment of tardive dyskinesia in a patient with severe orofacial symptoms: A case report.
    Wietholter JP; Sizemore J; Piechowski K
    Am J Health Syst Pharm; 2020 Sep; 77(18):1477-1481. PubMed ID: 32761113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
    Niemann N; Jankovic J
    Drugs; 2018 Apr; 78(5):525-541. PubMed ID: 29484607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole as a viable alternative for treating delusions of parasitosis.
    Ladizinski B; Busse KL; Bhutani T; Koo JY
    J Drugs Dermatol; 2010 Dec; 9(12):1531-2. PubMed ID: 21120263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients.
    Witter DP; Holbert RC; Suryadevara U
    Expert Opin Pharmacother; 2017 Jul; 18(10):965-972. PubMed ID: 28443349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valbenazine as the first and only approved treatment for adults with tardive dyskinesia.
    Sarva H; Henchcliffe C
    Expert Rev Clin Pharmacol; 2018 Mar; 11(3):209-217. PubMed ID: 29338466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative approach for managing tardive dyskinesia: A case report.
    Kulamarva K; Karanth V; Chikkanna U; Bhargav H; Holla B; Ramakrishna KK; Jasti N; Varambally S
    Explore (NY); 2023; 19(6):865-867. PubMed ID: 37217392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Focused Update on Tardive Dyskinesia.
    Blanchet PJ
    Can J Neurol Sci; 2020 Nov; 47(6):747-755. PubMed ID: 32624027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deutetrabenazine in the treatment of tardive dyskinesia.
    Niemann N; Jimenez-Shahed J
    Neurodegener Dis Manag; 2019 Apr; 9(2):59-71. PubMed ID: 30702019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive Dyskinesia in Older Persons Taking Antipsychotics.
    Citrome L; Isaacson SH; Larson D; Kremens D
    Neuropsychiatr Dis Treat; 2021; 17():3127-3134. PubMed ID: 34703232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia.
    Meyer JM
    CNS Spectr; 2016 Dec; 21(S1):13-24. PubMed ID: 28044943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive Dyskinesia: New Treatments Available.
    Limandri BJ
    J Psychosoc Nurs Ment Health Serv; 2019 May; 57(5):11-14. PubMed ID: 31042295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VMAT2 Inhibitors for the Treatment of Tardive Dyskinesia.
    Warren B; Vanderhoef D; Johnson J
    Issues Ment Health Nurs; 2022 Jan; 43(1):22-31. PubMed ID: 34370608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.